PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
33991534-7	2021	Additionally, the expression levels of retinoid-related orphan receptor alpha (RORalpha) and retinoic acid receptor alpha (RARalpha) were lower in the cerebellum of ASD rats with VAD than in those of ASD rats with VAN.	van	214-217	RAR-related orphan receptor A	Rattus norvegicus	79-87
33991534-7	2021	Additionally, the expression levels of retinoid-related orphan receptor alpha (RORalpha) and retinoic acid receptor alpha (RARalpha) were lower in the cerebellum of ASD rats with VAD than in those of ASD rats with VAN.	van	214-217	retinoic acid receptor, alpha	Rattus norvegicus	93-121
33991534-7	2021	Additionally, the expression levels of retinoid-related orphan receptor alpha (RORalpha) and retinoic acid receptor alpha (RARalpha) were lower in the cerebellum of ASD rats with VAD than in those of ASD rats with VAN.	van	214-217	retinoic acid receptor, alpha	Rattus norvegicus	123-131
29534734-7	2018	Relative to the VAD group, the VAN group also had increased mRNA and protein levels of RARalpha and PI3K, and upregulated phosphorylated Akt/Bad levels in vivo.	van	31-34	retinoic acid receptor, alpha	Rattus norvegicus	87-95
33361554-5	2021	In the presence of TOB (VAN/TOB-P), >90% of VAN was released within 3 days (p<0.05).	van	24-27	transducer of ErbB-2.1	Mus musculus	19-22
33361554-13	2021	We propose that a distinctive release profile of VAN and TOB observed is mainly due to different distribution pattern of VAN and TOB within P-DCPD matrix.	van	49-52	transducer of ErbB-2.1	Mus musculus	129-132
33052059-8	2021	Compared with VAN-treated SHRs, LRAT, retinoic acid receptor alpha (RARalpha), ACE2, and Ang (1-7) protein expression levels were decreased, while ACE and AT1R expression levels were increased in VAD SHRs.	van	14-17	lecithin retinol acyltransferase	Homo sapiens	32-36
33052059-8	2021	Compared with VAN-treated SHRs, LRAT, retinoic acid receptor alpha (RARalpha), ACE2, and Ang (1-7) protein expression levels were decreased, while ACE and AT1R expression levels were increased in VAD SHRs.	van	14-17	retinoic acid receptor alpha	Homo sapiens	38-66
33052059-8	2021	Compared with VAN-treated SHRs, LRAT, retinoic acid receptor alpha (RARalpha), ACE2, and Ang (1-7) protein expression levels were decreased, while ACE and AT1R expression levels were increased in VAD SHRs.	van	14-17	retinoic acid receptor alpha	Homo sapiens	68-76
33052059-8	2021	Compared with VAN-treated SHRs, LRAT, retinoic acid receptor alpha (RARalpha), ACE2, and Ang (1-7) protein expression levels were decreased, while ACE and AT1R expression levels were increased in VAD SHRs.	van	14-17	angiotensin converting enzyme 2	Homo sapiens	79-83
33052059-8	2021	Compared with VAN-treated SHRs, LRAT, retinoic acid receptor alpha (RARalpha), ACE2, and Ang (1-7) protein expression levels were decreased, while ACE and AT1R expression levels were increased in VAD SHRs.	van	14-17	angiopoietin 1	Homo sapiens	89-97
33052059-8	2021	Compared with VAN-treated SHRs, LRAT, retinoic acid receptor alpha (RARalpha), ACE2, and Ang (1-7) protein expression levels were decreased, while ACE and AT1R expression levels were increased in VAD SHRs.	van	14-17	angiotensin I converting enzyme	Homo sapiens	79-82
33052059-8	2021	Compared with VAN-treated SHRs, LRAT, retinoic acid receptor alpha (RARalpha), ACE2, and Ang (1-7) protein expression levels were decreased, while ACE and AT1R expression levels were increased in VAD SHRs.	van	14-17	angiotensin II receptor type 1	Homo sapiens	155-159
32917985-2	2021	Leptin modulates responsiveness of VAN to meal-related gastrointestinal signals.	van	35-38	leptin	Mus musculus	0-6
32917985-3	2021	Rodents with high-fat diet (HF) feeding develop leptin resistance that impairs responsiveness of VAN.	van	97-100	leptin	Mus musculus	48-54
32946754-4	2020	We hypothesized that VAN-mediated processes are influenced by ghrelin, a stomach-derived orexigenic hormone, via communication to its receptor (GHSR) expressed on gut-innervating VANs.	van	21-24	ghrelin and obestatin prepropeptide	Rattus norvegicus	62-69
32946754-4	2020	We hypothesized that VAN-mediated processes are influenced by ghrelin, a stomach-derived orexigenic hormone, via communication to its receptor (GHSR) expressed on gut-innervating VANs.	van	21-24	growth hormone secretagogue receptor	Rattus norvegicus	144-148
32946754-8	2020	A functional role for endogenous VAN GHSR signaling was further confirmed by results revealing that VAN signaling is required for the hyperphagic effects of ghrelin administered at dark onset, and that gut-restricted ghrelin-induced increases in VAN firing rate require intact VAN GHSR expression.	van	33-36	growth hormone secretagogue receptor	Homo sapiens	37-41
32946754-8	2020	A functional role for endogenous VAN GHSR signaling was further confirmed by results revealing that VAN signaling is required for the hyperphagic effects of ghrelin administered at dark onset, and that gut-restricted ghrelin-induced increases in VAN firing rate require intact VAN GHSR expression.	van	33-36	ghrelin and obestatin prepropeptide	Rattus norvegicus	157-164
32946754-8	2020	A functional role for endogenous VAN GHSR signaling was further confirmed by results revealing that VAN signaling is required for the hyperphagic effects of ghrelin administered at dark onset, and that gut-restricted ghrelin-induced increases in VAN firing rate require intact VAN GHSR expression.	van	33-36	ghrelin and obestatin prepropeptide	Rattus norvegicus	217-224
32946754-8	2020	A functional role for endogenous VAN GHSR signaling was further confirmed by results revealing that VAN signaling is required for the hyperphagic effects of ghrelin administered at dark onset, and that gut-restricted ghrelin-induced increases in VAN firing rate require intact VAN GHSR expression.	van	33-36	growth hormone secretagogue receptor	Homo sapiens	281-285
32946754-8	2020	A functional role for endogenous VAN GHSR signaling was further confirmed by results revealing that VAN signaling is required for the hyperphagic effects of ghrelin administered at dark onset, and that gut-restricted ghrelin-induced increases in VAN firing rate require intact VAN GHSR expression.	van	100-103	growth hormone secretagogue receptor	Homo sapiens	37-41
32946754-8	2020	A functional role for endogenous VAN GHSR signaling was further confirmed by results revealing that VAN signaling is required for the hyperphagic effects of ghrelin administered at dark onset, and that gut-restricted ghrelin-induced increases in VAN firing rate require intact VAN GHSR expression.	van	100-103	ghrelin and obestatin prepropeptide	Rattus norvegicus	157-164
32946754-8	2020	A functional role for endogenous VAN GHSR signaling was further confirmed by results revealing that VAN signaling is required for the hyperphagic effects of ghrelin administered at dark onset, and that gut-restricted ghrelin-induced increases in VAN firing rate require intact VAN GHSR expression.	van	100-103	growth hormone secretagogue receptor	Homo sapiens	37-41
32946754-8	2020	A functional role for endogenous VAN GHSR signaling was further confirmed by results revealing that VAN signaling is required for the hyperphagic effects of ghrelin administered at dark onset, and that gut-restricted ghrelin-induced increases in VAN firing rate require intact VAN GHSR expression.	van	100-103	ghrelin and obestatin prepropeptide	Rattus norvegicus	157-164
32526256-7	2020	Besides, the expression levels of retinoic acid receptor alpha (RARalpha) and Ret in autism model rats with VAD were decreased compared with those in rats with VAN.	van	160-163	retinoic acid receptor, alpha	Rattus norvegicus	34-62
32277698-10	2020	The VAN-DCS antagonism is due to a mechanism that we named van-mediated Ddl inhibition bypass.	van	59-62	AT695_RS07115	Staphylococcus aureus	72-75
31203170-12	2019	Psychophysiological interaction showed a negative relationship between the DAN and the VAN for high versus low load conditions in patients.	van	87-90	NBL1, DAN family BMP antagonist	Homo sapiens	75-78
29534734-7	2018	Relative to the VAD group, the VAN group also had increased mRNA and protein levels of RARalpha and PI3K, and upregulated phosphorylated Akt/Bad levels in vivo.	van	31-34	AKT serine/threonine kinase 1	Rattus norvegicus	137-140
28705805-3	2017	We report that CCK-SAP ablates a subpopulation of VAN in culture.	van	50-53	cholecystokinin	Rattus norvegicus	15-18
22412960-9	2012	The lowered sensitivity of VAN to CCK in DIO rats resulted in a decrease in Y2 expression and increased CB1 and MCH1R expression.	van	27-30	cholecystokinin	Rattus norvegicus	34-37
22412960-9	2012	The lowered sensitivity of VAN to CCK in DIO rats resulted in a decrease in Y2 expression and increased CB1 and MCH1R expression.	van	27-30	cannabinoid receptor 1	Rattus norvegicus	104-107
22412960-9	2012	The lowered sensitivity of VAN to CCK in DIO rats resulted in a decrease in Y2 expression and increased CB1 and MCH1R expression.	van	27-30	melanin-concentrating hormone receptor 1	Rattus norvegicus	112-117
35215272-10	2022	Out of all PEGylated derivatives, VAN:PEG1 and VAN:PEG3 were able to overcome vanC resistance.	van	34-37	mesoderm specific transcript	Homo sapiens	38-42
35215272-10	2022	Out of all PEGylated derivatives, VAN:PEG1 and VAN:PEG3 were able to overcome vanC resistance.	van	47-50	paternally expressed 3	Homo sapiens	51-55
26456775-11	2016	5-HT and cholecystokinin (CCK) induced dose-dependent increases in VAN activity in all rats; HFD attenuated the response to CCK, but not 5-HT.	van	67-70	cholecystokinin	Rattus norvegicus	26-29